Advertising on the portal

Institute of Nuclear Medicine. Leading centers and clinics in the field of nuclear medicine in Russia Laboratory of Nuclear Medicine

Russia is a nuclear power with extensive experience in the use of nuclear technologies in a wide variety of areas of human activity. Nuclear medicine, including the use of radionuclides for the diagnosis and treatment of diseases, began to develop in our country at the turn of the 40-50s. Modern nuclear medicine is a set of technologies that make it possible to study the blood supply to the brain and evaluate the functioning of internal organs and systems by scanning according to the tomography principle.

Nuclear medicine in Russia

Reviews from patients indicate that today nuclear medicine in Russia has firmly taken a leading position in the field of early diagnosis and treatment of malignant pathologies. Such operations are carried out at different stages and for different forms of oncology; only the type of radionuclide used changes. Russian surgeons have successfully mastered new technologies for the treatment of malignant liver lesions, hormonal tumors of the gastrointestinal tract, throat, thyroid gland and other serious diseases using radioembolization and radioimmunotherapy, cyber knives, and the Da Vinci robot.

Nuclear medicine in Russia: prices

Operation using the Da Vinci robot - from 380 rubles, Gamma Knife - 220 thousand rubles.

One of the activities of the Rosatom State Corporation is the development of nuclear medicine (medical diagnostics and radiation therapy used in the treatment of oncological, cardiac and neurological diseases). This problem is being solved by the integrator in this area - JSC Rusatom Healthcare, which has united a number of leading manufacturers in the domestic industry - JSC NIITFA (equipment production), JSC V/O Isotope (production of radionuclides), JSC NIFHI im. L.Ya. Karpov" (production of radiopharmaceuticals), JSC "Rusreactor" (production of low-power reactors for the production of radionuclides), as well as two centers for the production of radiopharmaceuticals based on ultra-short-lived radionuclides - fluorine-18, carbon-11, nitrogen-13 and oxygen-15 for PET - diagnostics. Work is actively underway to create and bring to market an import-substituting radiotherapy complex based on a linear electron accelerator with an energy of 6 MeV for precision radiation therapy of malignant tumors. The first such accelerators will appear in 2022. Work is also underway to create a network of nuclear medicine centers in the country. One of them will be built in the coming years in Irkutsk. Similar centers are planned to be built in other regions of Russia.

Today, over 50% of radioactive isotopes produced in the world are used for medical needs. As part of its efforts to develop domestic nuclear medicine, the Rosatom State Corporation organized the production of the molybdenum-99 isotope at the State Scientific Center “Research Institute of Atomic Reactors” (Dimitrovgrad, Ulyanovsk region). The project is aimed at organizing Russia’s own production of new radiopharmaceuticals and medical devices, and developing services to provide high-tech medical care to the population.

The Federal State Unitary Enterprise “Federal Center for the Design and Development of Nuclear Medicine Facilities” of the FMBA of Russia was created by order of the FMBA of Russia on September 1, 2010 in connection with the emerging demand for the industry developing in the country. Currently, the enterprise's portfolio includes more than 30 medical radiological institutions, where the Federal Center took part at various stages of their creation (from conceptual and design development to commissioning). Among them are 8 radionuclide diagnostic departments with gamma cameras or SPECT, 7 positron emission tomography centers, 5 radionuclide therapy departments, 6 radiation therapy departments (remote and contact), 3 laboratories for the production of medical radioisotope products, 2 large medical radiology centers (with consisting of the above departments), including the Federal High-Technology Center for Medical Radiology of the FMBA of Russia in Dimitrovgrad. The development of design documentation is carried out by qualified employees of the branch of the Central Design Institute of Nuclear Medicine, St. Petersburg. The competencies of the personnel working at the Center allow the company to perform the function of a General Contractor; a full package of permits has been drawn up, necessary in accordance with legal requirements for the design and construction of radiation hazardous facilities.

At all stages of project implementation, the Federal Center provides scientific and technical engineering support for the creation of nuclear medicine facilities, based on existing experience, taking into account the specifics of the current regulatory framework, the requirements of state regulatory authorities and the market situation.

A branch of the Federal Center, the Medradiopreparat plant is Russia's largest manufacturer of radiopharmaceutical products, which for more than 40 years has been supplying the Russian and neighboring markets with more than 12 types of radiopharmaceuticals and medical products based on radionuclides 131 I, 123 I, 89 Sr, 67 Ga, 111In. After reconstruction in 2010, the enterprise had the necessary conditions that meet GMP requirements for the production and quality control of medicines. Together with leading scientific centers (FMBC named after A.I. Burnazyan, FMBA of Russia, MRRC of the Ministry of Health of the Russian Federation, RNTsRR of the Ministry of Health of the Russian Federation and many others), the development of the latest drugs using radioisotopes 188 Re, 68 Ga, 90 Y, 99m Tc and radionuclide generators with introduction of innovative methods and modern technologies for the diagnosis and treatment of cancer and other socially significant diseases.

Since 2016, for the first time in Russia, the production of a new capsule form of the drug “Sodium iodide 131” with proven safety and effectiveness has been organized.

The enterprise carries out scientific and innovative activities in the preparation of expert opinions, recommendations, reference materials regarding regulatory issues, permitting and production documentation, selection of technological equipment, statistical data and other information in the field of radiation medical technologies, including participation in the preparation of the interdepartmental State program "Development nuclear medicine in the Russian Federation".

Structure

​ The Institute of Nuclear Medicine at Assaf Harofeh Medical Center offers many different nuclear medicine imaging studies, from various types of bone mapping to adrenal and tumor mapping

Scintigraphy

Nuclear medicine

This is an avant-garde, non-invasive method of examining and treating pathologies of various organs and systems at the molecular level, which makes it possible to identify the disease long before the appearance of anatomical disorders and, if necessary, treat it with minimal irradiation of healthy tissue.
The use of minimal doses of drugs in combination with the latest equipment and highly qualified personnel guarantees you a convenient, fast and accurate examination.
Most of the team speaks Russian.
The production of all drugs is carried out in a licensed radiopharmaceutical laboratory. This guarantees high reliability, quality of drugs and their compliance with all international standards.
Our department is equipped with modern equipment, including a 64-slice PET/CT and three gamma cameras, including a Combined SPECT/CT system, which provides simultaneous acquisition of diagnostic information for both types of studies.
The work of the department is divided between four main areas: oncology, neurology, cardiology and general nuclear medicine.

NUCLEAR ONCOLOGY

64 - slice PET / CT with high throughput, well-functioning professional work of the entire team, will help you in comfortable individual waiting rooms to undergo optimal preparation and visualization of various oncological processes.
The purpose of this survey:

  • Diagnostics
  • Determination of stage
  • Treatment planning
  • Tracking treatment results

Preoperative identification of first-order lymph nodes allows the surgeon to take only the necessary lymph nodes for biopsy without disturbing the regional lymph flow.

NUCLEAR CARDIOLOGY

Certified cardiologists, together with specialists in the field of nuclear medicine, will select the optimal form of cardiovascular research for you.
The list of studies includes:

  • Assessment of the functioning of the right and left ventricles at rest.
  • Visualization of blood supply
    cardiac muscle during exercise and
    rest, etc. d.

NUCLEAR NEUROLOGY

The head of the department is the only certified specialist in the field of nuclear neurology in the country. The department carries out highly specialized examination methods:

  • Identification of the focus of epilepsy for further operational intervention.
  • Diagnosis of various types of dementia.
  • Visualization of the consequences of traumatic brain injury, including the case of absence of abnormalities on CT, with ongoing complaints of the patient.
  • Determination of the possibility, central nature of persistent ringing in the ears (tinitus).
  • Diagnosis of Parkinson's disease.
  • Forecasting and objective
    assessment of the results of treatment of central nervous system pathologies in the hyperbaric oxygenation (HBO) department.

NUCLEAR MOLECULAR THERAPY

​The services of our department include treatment with radioisotope preparations for such pathologies as:

  • Benign diseases, thyroid gland.
  • Thyroid malignancies and follow-up with radioactive iodine without having to stop hormone replacement therapy.
  • Detection of neuroendocrine tumors and their therapy.
  • Treatment of bone metastases of a tumor, prostate gland using radioactive radium.

GENERAL NUCLEAR MEDICINE

The list of diagnosed pathologies will include:

  • Visualization of bone system pathology for diagnostic purposes:
    - Injuries and fractures that cannot be diagnosed by conventional examination methods.
    - Joint pathologies
    - Complications after prosthetics
    - Detection of primary tumors and bone metastases and monitoring of their treatment, etc. d.
  • Detection of kidney pathology, starting
    from the age of one month of the patient. This list includes:
    - Urolithiasis
    - Narrowing of the ureter in its various parts.
    - Pyelonephritis and visualization of scar-
    new changes in the kidneys.
    - Vesicoureteral reflux
    - Tumors of the urinary system
  • A study of the function of the gastrointestinal tract allows us to diagnose the causes:
    - Swallowing disorders
    - Gastric emptying problems
    - Pathological reflux of contents -
    of the stomach into the esophagus and its complications.
  • Using our technology, it becomes possible to detect recurrent bleeding, including intestinal bleeding.
  • Examination with labeled red blood cells
    mi gives an accurate diagnosis of hemangiomas in the liver.
  • Identifying the location of the adenoma
    parathyroid gland in a non-invasive manner, with the aim of minimizing surgical intervention.
  • On the basis of our department it is carried out
    a procedure for preoperative non-invasive identification of the best site for microsurgical treatment of impaired lymphatic drainage (lymphedema).¬